Short Summary
Apple Inc. filed a motion to dismiss its IPR petition against Telcom Ventures' U.S. Patent 12,028,793, arguing that the Board has not yet ruled on institution and that proceeding would waste resources. The motion seeks pre‑institution dismissal while other related IPRs remain active in parallel litigation.
Detailed Summary
In IPR2025-01239, Apple Inc. moved to dismiss its petition for inter partes review of Telcom Ventures LLC's U.S. Patent No. 12,028,793, which covers claims 1‑11. Citing 37 C.F.R. §§ 42.71(a) and 42.72, Apple contended that the Board has not yet decided on institution and that dismissing the petition would conserve resources for both the Board and the parties, especially as the patent has already been dismissed with prejudice in related district‑court litigation. The motion also references other pending IPRs that remain asserted, emphasizing the need to focus on those matters.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Apple Inc. vs Telcom Ventures LLC is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Godbersen-Smith Construction Company d/b/a GOMACO CorporationvsGuntert & Zimmerman Const. Div., Inc.
GOMACO has filed a post‑grant review petition seeking cancellation of claims 1‑7 of its ‘723 slipform paver patent. The petition alleges obviousness over the CIII manual, Rio and Files patents, and a lack of written description for a transducer placement. The Board has yet to decide whether to institute the proceeding.
Tesla, Inc.vsIntellectual Ventures II LLC
Tesla challenged the validity of a target recognition patent (6894639) before the PTAB. The Board granted institution, finding that the Petitioner showed a reasonable likelihood of prevailing in challenging at least one claim under § 103 over Barnard. This decision moves the case forward for substantive review on obviousness grounds.
Apotex Inc. et al.vsAlkermes Pharma Ireland Limited
Apotex petitions the PTAB to review US 7,919,499, covering a long‑acting naltrexone formulation, asserting that the claims are anticipated or obvious over Comer, Nuwayser, Rubio and Wright. The petition cites a prior IPR that was instituted and later terminated, and argues that discretionary denial is unwarranted.
Activision Blizzard, Inc.vsMilestone Entertainment, LLC
Activision Blizzard’s IPR petition targeting Milestone Entertainment’s virtual‑currency gaming patent was rejected. The patent owner showed the prior art fails to disclose key claim elements and that no motivation to combine existed.
Home Depot U.S.A., Inc.vsH2 Intellect LLC
Home Depot seeks Director Review of the PTAB’s denial to institute an IPR against H2 Intellect’s location‑based advertising patent. The petitioner contends the Board misapplied claim construction and ignored obviousness of key limitations. The request urges reversal of the denial.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.